|
|
Volumn 104, Issue 4, 1998, Pages 332-338
|
|
Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
CARDIOLIPIN ANTIBODY;
DICOUMAROL;
FIBRINOLYTIC AGENT;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
PROTHROMBIN;
WARFARIN;
ADULT;
ANTIBODY TITER;
ANTICOAGULANT THERAPY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DOUBLE BLIND PROCEDURE;
FEMALE;
FIBRINOLYTIC THERAPY;
FOLLOW UP;
HEPARINIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PREDICTION;
PRIORITY JOURNAL;
PROTHROMBIN TIME;
RANDOMIZED CONTROLLED TRIAL;
RECURRENCE RISK;
RECURRENT DISEASE;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOEMBOLISM;
VEIN THROMBOSIS;
|
|
EID: 0031919292
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(98)00060-6 Document Type: Article |
|
Times cited : (474)
|
|
References (2)
|
